HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

DBM-819

structure in first source

Also Known As:

1-(2-methyl-4-methoxyphenyl)-4-((3-hydroxypropyl)amino)-6-methyl-2,3-dihydropyrrolo(3,2-c)quinoline

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - DBM-819: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - DBM-819: 1

Experts

1.	Cheon, H G: 1 article (01/2001)
2.	Lee, D H: 1 article (01/2001)
3.	Lee, S S: 1 article (01/2001)
4.	Lim, H: 1 article (01/2001)

Related Diseases

1.	Ulcer 01/05/2001 - "Taken together, these results suggest that DBM-819 acts as an effective oral anti-ulcer agent in vivo, and that DBM-819 could be developed as a new therapeutic agent for peptic ulcer disease."
2.	Peptic Ulcer (Peptic Ulcers) 01/05/2001 - "Taken together, these results suggest that DBM-819 acts as an effective oral anti-ulcer agent in vivo, and that DBM-819 could be developed as a new therapeutic agent for peptic ulcer disease."
3.	Gastric Fistula 01/05/2001 - "The duration of the anti-secretory effect was approximately 18 h when DBM-819 was administered orally to rats with a chronic gastric fistula. "
4.	Duodenal Ulcer (Curling's Ulcer) 01/05/2001 - "Oral administration of DBM-819 protected against gastric lesions induced by ethanol, NaOH, indomethacin and aspirin, and the duodenal ulcer induced by cysteamine, in a dose-dependent manner with ED(50) values of 7.0, 20, 3.1, 4.0 and 6.0 mg/kg, respectively. "

Related Drugs and Biologics

1.	Indomethacin (Indometacin)
2.	Cysteamine (Mercaptamine)
3.	Aspirin (Acetylsalicylic Acid)
4.	Ethanol (Ethyl Alcohol)

Related Therapies and Procedures

1.	Oral Administration